Published in Antimicrob Agents Chemother on January 19, 2010
APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res (2015) 1.22
Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300. Int J Antimicrob Agents (2012) 1.06
Ab initio design of potent anti-MRSA peptides based on database filtering technology. J Am Chem Soc (2012) 1.06
Database-Guided Discovery of Potent Peptides to Combat HIV-1 or Superbugs. Pharmaceuticals (Basel) (2013) 0.90
Improved methods for classification, prediction, and design of antimicrobial peptides. Methods Mol Biol (2015) 0.89
High-resolution structures and orientations of antimicrobial peptides piscidin 1 and piscidin 3 in fluid bilayers reveal tilting, kinking, and bilayer immersion. J Am Chem Soc (2014) 0.87
The Importance of Amino Acid Composition in Natural AMPs: An Evolutional, Structural, and Functional Perspective. Front Immunol (2012) 0.86
Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development. Curr HIV Res (2012) 0.85
Design and surface immobilization of short anti-biofilm peptides. Acta Biomater (2016) 0.84
Structural location determines functional roles of the basic amino acids of KR-12, the smallest antimicrobial peptide from human cathelicidin LL-37. RSC Adv (2013) 0.83
Amphipathic antimicrobial piscidin in magnetically aligned lipid bilayers. Biophys J (2011) 0.83
Host defense antimicrobial peptides as antibiotics: design and application strategies. Curr Opin Chem Biol (2017) 0.76
Insights into Antimicrobial Peptides from Spiders and Scorpions. Protein Pept Lett (2016) 0.75
Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model. Antimicrob Agents Chemother (2015) 0.75
Natural antimicrobial peptides as promising anti-HIV candidates. Curr Top Pept Protein Res (2016) 0.75
Simulations of Membrane-Disrupting Peptides II: AMP Piscidin 1 Favors Surface Defects over Pores. Biophys J (2016) 0.75
Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (1985) 30.62
CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA. Cancer (1965) 8.54
Peptide antimicrobial agents. Clin Microbiol Rev (2006) 6.04
APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res (2008) 4.23
New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J Natl Cancer Inst (1989) 4.04
Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res Hum Retroviruses (1987) 3.67
APD: the Antimicrobial Peptide Database. Nucleic Acids Res (2004) 3.60
Quantitative infectivity assay for HIV-1 and-2. Nature (1988) 3.01
Considerations and development of topical microbicides to inhibit the sexual transmission of HIV. Expert Opin Investig Drugs (2002) 2.06
Interaction between heat shock proteins and antimicrobial peptides. Biochemistry (2000) 1.66
The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr HIV Res (2007) 1.50
Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J Gen Virol (1998) 1.36
Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilide. Antimicrob Agents Chemother (1995) 1.31
Buforins: histone H2A-derived antimicrobial peptides from toad stomach. Biochim Biophys Acta (2008) 1.25
Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins. Antimicrob Agents Chemother (2008) 1.20
Multispecific myeloid defensins. Curr Opin Hematol (2007) 1.15
Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophils. J Leukoc Biol (1998) 1.15
NMR studies of aurein 1.2 analogs. Biochim Biophys Acta (2006) 1.01
Antimicrobial peptide microbicides targeting HIV. Protein Pept Lett (2005) 0.96
Cyclotides as natural anti-HIV agents. Biopolymers (2008) 0.95
Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection. Expert Opin Investig Drugs (2001) 0.82
The synthetic [Tyr5,12,Lys7]-polyphemusin II peptide (T22) binds to the CD4 cell surface molecule. Biochem Biophys Res Commun (1995) 0.80
In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials. AIDS Res Hum Retroviruses (2005) 3.89
Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J Biol Chem (2004) 2.07
Synthesis and anti-HIV activity of new metabolically stable alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors incorporating N-methoxy imidoyl halide and 1,2,4-oxadiazole systems. J Med Chem (2007) 1.76
Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides. Antimicrob Agents Chemother (2008) 1.68
Escherichia coli enzyme IIANtr regulates the K+ transporter TrkA. Proc Natl Acad Sci U S A (2007) 1.52
Carrageenan/MIV-150 (PC-815), a combination microbicide. Sex Transm Dis (2007) 1.40
A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium. Biochemistry (2003) 1.37
In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories. Antimicrob Agents Chemother (2006) 1.37
Structure of phosphorylated enzyme I, the phosphoenolpyruvate:sugar phosphotransferase system sugar translocation signal protein. Proc Natl Acad Sci U S A (2006) 1.33
Development of topical microbicides to prevent the sexual transmission of HIV. Antiviral Res (2009) 1.30
Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob Agents Chemother (2003) 1.29
Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1. Antimicrob Agents Chemother (2011) 1.25
Requirement of the dephospho-form of enzyme IIANtr for derepression of Escherichia coli K-12 ilvBN expression. Mol Microbiol (2005) 1.22
Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins. Antimicrob Agents Chemother (2008) 1.20
In vitro reconstitution of catabolite repression in Escherichia coli. J Biol Chem (2006) 1.18
Novel targets for HIV therapy. Antiviral Res (2008) 1.15
Gap junction turnover is achieved by the internalization of small endocytic double-membrane vesicles. Mol Biol Cell (2009) 1.11
Solution structure of the phosphoryl transfer complex between the cytoplasmic A domain of the mannitol transporter IIMannitol and HPr of the Escherichia coli phosphotransferase system. J Biol Chem (2002) 1.10
Vaginal film drug delivery of the pyrimidinedione IQP-0528 for the prevention of HIV infection. Pharm Res (2012) 1.10
A novel fermentation/respiration switch protein regulated by enzyme IIAGlc in Escherichia coli. J Biol Chem (2004) 1.09
Optimization of unique, uncharged thioesters as inhibitors of HIV replication. Bioorg Med Chem (2004) 1.02
Green-to-red photoconvertible fluorescent proteins: tracking cell and protein dynamics on standard wide-field mercury arc-based microscopes. BMC Cell Biol (2010) 1.02
NMR studies of aurein 1.2 analogs. Biochim Biophys Acta (2006) 1.01
Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection. J Pharm Sci (2012) 1.01
Solution NMR structure of the 48-kDa IIAMannose-HPr complex of the Escherichia coli mannose phosphotransferase system. J Biol Chem (2005) 1.01
The structure-activity relationships of 2,4(1H,3H)-pyrimidinedione derivatives as potent HIV type 1 and type 2 inhibitors. Antivir Chem Chemother (2007) 1.00
Comparative evaluation of the inhibitory activities of a series of pyrimidinedione congeners that inhibit human immunodeficiency virus types 1 and 2. Antimicrob Agents Chemother (2007) 1.00
"Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gels. AIDS Behav (2014) 1.00
Synthesis and anti-HIV activity of new alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors (NNRTIs) incorporating benzoxazolone and benzisoxazole rings. Bioorg Med Chem (2006) 0.99
Binding of enzyme IIAGlc, a component of the phosphoenolpyruvate:sugar phosphotransferase system, to the Escherichia coli lactose permease. Biochemistry (2002) 0.98
Potassium mediates Escherichia coli enzyme IIA(Ntr) -dependent regulation of sigma factor selectivity. Mol Microbiol (2010) 0.97
Susceptibilities of simian immunodeficiency virus to protease inhibitors. Antimicrob Agents Chemother (2003) 0.95
Enzyme I: the gateway to the bacterial phosphoenolpyruvate:sugar phosphotransferase system. Arch Biochem Biophys (2002) 0.95
Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy. Retrovirology (2011) 0.95
Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors. Eur J Med Chem (2008) 0.95
Synthesis, anti-HIV activity, and metabolic stability of new alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors. J Med Chem (2005) 0.95
Three-dimensional solution structure of the cytoplasmic B domain of the mannitol transporter IImannitol of the Escherichia coli phosphotransferase system. J Biol Chem (2004) 0.94
HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice. J Virol (2014) 0.94
Safety and efficacy of tenofovir/IQP-0528 combination gels - a dual compartment microbicide for HIV-1 prevention. Antiviral Res (2012) 0.93
Reciprocal regulation of the autophosphorylation of enzyme INtr by glutamine and α-ketoglutarate in Escherichia coli. Mol Microbiol (2013) 0.93
Synthesis and biological evaluation of alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors that possess increased hydrolytic stability. J Med Chem (2007) 0.93
Development of dual-acting pyrimidinediones as novel and highly potent topical anti-HIV microbicides. Antimicrob Agents Chemother (2011) 0.92
Synthesis of alkenyldiarylmethane (ADAM) non-nucleoside HIV-1 reverse transcriptase inhibitors with non-identical aromatic rings. Bioorg Med Chem (2002) 0.91
Interdomain interaction and substrate coupling effects on dimerization and conformational stability of enzyme I of the Escherichia coli phosphoenolpyruvate:sugar phosphotransferase system. Biochemistry (2002) 0.91
Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV. Antimicrob Agents Chemother (2010) 0.90
Comparative evaluation of virus transmission inhibition by dual-acting pyrimidinedione microbicides using the microbicide transmission and sterilization assay. Antimicrob Agents Chemother (2008) 0.90
Dephosphorylated NPr of the nitrogen PTS regulates lipid A biosynthesis by direct interaction with LpxD. Biochem Biophys Res Commun (2011) 0.90
Replacement of the metabolically labile methyl esters in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors with isoxazolone, isoxazole, oxazolone, or cyano substituents. J Med Chem (2006) 0.89
Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme. J Med Chem (2007) 0.89
Opposing effects of phosphoenolpyruvate and pyruvate with Mg(2+) on the conformational stability and dimerization of phosphotransferase enzyme I from Escherichia coli. Protein Sci (2003) 0.88
Binaphthyl-based dicationic peptoids with therapeutic potential. Angew Chem Int Ed Engl (2010) 0.88
Solution structure of the N-terminal amphitropic domain of Escherichia coli glucose-specific enzyme IIA in membrane-mimetic micelles. Protein Sci (2003) 0.88
NMR characterization of the Escherichia coli nitrogen regulatory protein IIANtr in solution and interaction with its partner protein, NPr. Protein Sci (2005) 0.87
CD8+ T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants. Retrovirology (2013) 0.84
Expression, purification, and characterization of recombinant cyanovirin-N for vaginal anti-HIV microbicide development. Protein Expr Purif (2005) 0.84
Multivalent binding oligomers inhibit HIV Tat-TAR interaction critical for viral replication. Bioorg Med Chem Lett (2009) 0.84
Novel preclinical models of topical PrEP pharmacodynamics provide rationale for combination of drugs with complementary properties. Retrovirology (2013) 0.84
Solution structure of NPr, a bacterial signal-transducing protein that controls the phosphorylation state of the potassium transporter-regulating protein IIA Ntr. Amino Acids (2008) 0.83
Effects of detergent alkyl chain length and chemical structure on the properties of a micelle-bound bacterial membrane targeting peptide. Anal Biochem (2004) 0.83
The Continuing Evolution of HIV-1 Therapy: Identification and Development of Novel Antiretroviral Agents Targeting Viral and Cellular Targets. Mol Biol Int (2012) 0.83
Antiviral activity of hop constituents against a series of DNA and RNA viruses. Antiviral Res (2004) 0.82
Enzymatic triggered release of an HIV-1 entry inhibitor from prostate specific antigen degradable microparticles. Int J Pharm (2011) 0.82
Inhibition of human immunodeficiency virus type 1 by triciribine involves the accessory protein nef. Antimicrob Agents Chemother (2010) 0.81
Total synthesis of anibamine, a novel natural product as a chemokine receptor CCR5 antagonist. Org Lett (2007) 0.81
Deuteration of Escherichia coli enzyme I(Ntr) alters its stability. Arch Biochem Biophys (2010) 0.80
Crystallographic study of a novel subnanomolar inhibitor provides insight on the binding interactions of alkenyldiarylmethanes with human immunodeficiency virus-1 reverse transcriptase. J Med Chem (2009) 0.79
Antiviral interactions of combinations of highly potent 2,4(1H,3H)-pyrimidinedione congeners and other anti-HIV agents. Antiviral Res (2011) 0.79
Potent inhibition of HIV-1 entry by (s4dU)35. Virology (2005) 0.78
Antiviral amphipathic oligo- and polyribonucleotides: analogue development and biological studies. J Med Chem (2003) 0.78
Characterization of a lactose permease mutant that binds IIAGlc in the absence of ligand. Biochemistry (2003) 0.78
Evolution of an attenuated HIV-1 isolate in an elite suppressor. AIDS Res Hum Retroviruses (2013) 0.77
Factors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1. Mol Biol Int (2012) 0.77
In vitro and ex vivo evaluations on transdermal delivery of the HIV inhibitor IQP-0410. PLoS One (2013) 0.77
Synthesis of substituted diarylmethylenepiperidines (DAMPs), a novel class of anti-HIV agents. Bioorg Med Chem (2002) 0.77
1H, 15N, and 13C chemical shift assignments of the Escherichia coli nitrogen regulatory phosphocarrier IIA(Ntr). J Biomol NMR (2003) 0.77
Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitors. Bioorg Med Chem Lett (2007) 0.75
Cloning and expression of the gene for a novel protein from Mycobacterium smegmatis with functional similarity to eukaryotic calmodulin. J Bacteriol (2003) 0.75
Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors. Ther Deliv (2015) 0.75
Inhibition of tubulin polymerization by select alkenyldiarylmethanes. Bioorg Med Chem Lett (2007) 0.75
1-Benzyl derivatives of 5-(arylamino)uracils as anti-HIV-1 and anti-EBV agents. Bioorg Med Chem (2010) 0.75
"Senseless" antiviral polyribonucleotides: poly (1-propargylinosinic acid). Nucleosides Nucleotides Nucleic Acids (2002) 0.75
Selection and characterization of viruses resistant to the dual acting pyrimidinedione entry and non-nucleoside reverse transcriptase inhibitor IQP-0410. Antiviral Res (2013) 0.75
An unusual "senseless" 2',5'-oligoribonucleotide with potent anti-HIV activity. Nucleosides Nucleotides Nucleic Acids (2004) 0.75
Synthesis and anti-HIV activities of symmetrical dicarboxylate esters of dinucleoside reverse transcriptase inhibitors. Bioorg Med Chem Lett (2012) 0.75